| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69238-1704-3 | 69238-1704 | HUMAN PRESCRIPTION DRUG | deferasirox | deferasirox | GRANULE | ORAL | 20210209 | N/A | ANDA | ANDA214194 | Amneal Pharmaceuticals NY LLC | DEFERASIROX | 360 mg/1 | 30 PACKET in 1 CARTON (69238-1704-3) / 1 GRANULE in 1 PACKET (69238-1704-1) |
| 69238-1703-3 | 69238-1703 | HUMAN PRESCRIPTION DRUG | deferasirox | deferasirox | GRANULE | ORAL | 20210209 | N/A | ANDA | ANDA214194 | Amneal Pharmaceuticals NY LLC | DEFERASIROX | 180 mg/1 | 30 PACKET in 1 CARTON (69238-1703-3) / 1 GRANULE in 1 PACKET (69238-1703-1) |
| 69238-1702-3 | 69238-1702 | HUMAN PRESCRIPTION DRUG | deferasirox | deferasirox | GRANULE | ORAL | 20210804 | N/A | ANDA | ANDA214194 | Amneal Pharmaceuticals NY LLC | DEFERASIROX | 90 mg/1 | 30 PACKET in 1 CARTON (69238-1702-3) / 1 GRANULE in 1 PACKET (69238-1702-1) |